Sri Vijaya Medicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 09-12-2024
- Paid Up Capital ₹ 5.00 M
as on 09-12-2024
- Company Age 15 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 M
as on 09-12-2024
- Satisfied Charges ₹ 5.00 Cr
as on 09-12-2024
- Revenue -18.61%
(FY 2020)
- Profit -33.72%
(FY 2020)
- Ebitda -55.92%
(FY 2020)
- Net Worth 4.52%
(FY 2020)
- Total Assets -2.40%
(FY 2020)
About Sri Vijaya Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹2.50 M. The company has closed loans amounting to ₹5.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinodkumar and Kiruthika serve as directors at the Company.
- CIN/LLPIN
U24232TN2009PTC073618
- Company No.
073618
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sri Vijaya Medicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinodkumar  | Managing Director | 05-May-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiruthika | Director | 06-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Sri Vijaya Medicals.
Sri Vijaya Medicals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a substantial fall in profitability, with a 33.72% decrease in profit. The company's net worth moved up by a moderate rise of 4.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Vijaya Medicals?
In 2020, Sri Vijaya Medicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jul 2023 | ₹2.50 M | Open |
Deutsche Bank Ag Creation Date: 30 May 2014 | ₹3.00 Cr | Satisfied |
Citi Bank N.A. Creation Date: 01 Jun 2010 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Sri Vijaya Medicals?
Unlock and access historical data on people associated with Sri Vijaya Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Vijaya Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Vijaya Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
